Soru

Zorluk: OrtaGeneral Internal Medicine

A 70-year-old male with long-standing diabetic nephropathy arrives at the emergency department reporting profound generalized weakness and progressive palpitations that started earlier today. He missed his last two nephrology appointments and recently began taking an angiotensin-receptor blocker for uncontrolled hypertension. His heart rate is 55/min and blood pressure is 110/60 mmHg. An electrocardiogram is immediately obtained and demonstrates absent P waves, widening of the QRS complexes, and tall, symmetric, peaked T waves. Laboratory testing shows a serum potassium level of 7.47.4 mEq/L.

Arrange the following therapeutic interventions in the most appropriate chronological sequence for the acute stabilization and management of this patient.

  1. 1Administer intravenous calcium gluconate
  2. 2Administer intravenous regular insulin and 50% dextrose
  3. 3Administer an oral gastrointestinal potassium binder
  4. 4Prepare for urgent hemodialysis

Cevap

The correct chronological sequence is to first administer intravenous calcium gluconate to stabilize the myocardium, followed by intravenous regular insulin and dextrose to shift potassium intracellularly, then an oral gastrointestinal potassium binder to excrete potassium, and finally prepare for urgent hemodialysis if medical management is insufficient.
The correct sequence for severe symptomatic hyperkalemia prioritizes immediate myocardial protection over actual potassium reduction. Calcium gluconate acts within minutes to stabilize the cardiac action potential and prevent ventricular fibrillation. Next, intracellular shift agents (insulin + dextrose) are used to quickly lower serum potassium levels over the ensuing 30-60 minutes. Because intracellular shifting is only a temporary fix, the final phases involve removing total body potassium through the gastrointestinal tract (potassium binders) and ultimately the blood (hemodialysis), which take hours to take effect but provide definitive resolution.

Adım Adım Çözüm

1
Identify the immediate life-threatening emergency.
The patient has severe hyperkalemia (7.47.4 mEq/L) with critical electrocardiographic changes (widened QRS, absent P waves, peaked T waves).
These ECG changes indicate an imminent risk of fatal ventricular arrhythmias.
2
Select the intervention for immediate cardiac membrane stabilization.
Intravenous calcium gluconate is administered first.
Calcium antagonizes the depolarizing effects of hyperkalemia on the resting membrane potential, acting within 1-3 minutes to protect the heart.
3
Select the fastest intervention to lower serum potassium levels.
Intravenous regular insulin and dextrose are administered second.
Insulin drives potassium into the intracellular space via the Na-K-ATPase pump, effectively lowering extracellular potassium within 30 minutes. Dextrose prevents hypoglycemia.
4
Select interventions for total body potassium elimination.
An oral gastrointestinal potassium binder is given third, and preparations for hemodialysis are made fourth.
Intracellular shifts are temporary. Potassium must be permanently removed from the body. Binders act over hours to days. Hemodialysis is the ultimate definitive treatment if the patient is refractory or has end-stage renal disease.

Anahtar Kavram

The management of severe hyperkalemia with electrocardiographic changes follows a strict three-step sequence: 1) stabilize the cardiac membrane with calcium, 2) temporarily shift potassium intracellularly with insulin/glucose, and 3) definitively eliminate potassium from the body with diuretics, gastrointestinal binders, or hemodialysis.
Bu soruyu puanla